Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Infectious Disease
•
General Infectious Disease
Do you routinely use oral vancomycin prophylaxis in patients with a history of CDI who are receiving antibiotics?
Related Questions
Do you routinely offer suppressive antibiotics to patients with a prosthetic joint infection when surgery is delayed for months?
How do you factor cerebrospinal fluid (CSF) antibody results when deciding on the diagnosis and treatment of racemose neurocysticercosis, given the uncertainties associated with CSF antibody testing?
Do you routinely check cefepime levels in patient's with suspected cefepime-induced neurotoxicity?
Do you adhere to the standard 5-day minimum treatment duration for community-acquired pneumonia, or have you used shorter courses for certain low-risk patients?
Do you routinely recommend transition to dual PO antibiotic coverage for strep species and MRSA, for patients with purulent cellulitis and in the absence of culture data?
What is your approach to antiviral treatment of HSV acute retinal necrosis?
Do you recommend boric acid for patients with recurrent candida vulvovaginitis?
Do you give additional pneumococcal vaccines after a dose of PCV20 in patients with asplenia?
Is there a role for suppressive antibiotic therapy when it comes to chronic femoral/tibial osteomyelitis?
Would you use ceftriaxone for treatment of a deep seated infection such as vertebral osteomyelitis +/- epidural abscess caused by a low risk AmpC producing pathogen?
